Eosinophilic colitis
diseaseOn this page
Summary
Eosinophilic colitis (MONDO:0018439) is a disease and 7 clinical trials. A subtype of microscopic colitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Clinical trials: 7
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 196 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | eosinophilic colitis |
| Mondo ID | MONDO:0018439 |
| Orphanet | 402035 |
| ICD-10-CM | K52.82 |
| ICD-11 | 1169803773 |
| NCIT | C27053 |
| SNOMED CT | 29120000 |
| UMLS | C0267448 |
| MedGen | 75633 |
| GARD | 0021715 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of microscopic colitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › gastroenteritis › colitis › microscopic colitis › eosinophilic colitis
Related subtypes (2): collagenous colitis, lymphocytic colitis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 7.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 7 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02523118 | Not specified | RECRUITING | OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages |
| NCT05199532 | Not specified | RECRUITING | Eosinophilic Gastrointestinal Disorders Registry |
| NCT05219903 | Not specified | RECRUITING | National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders |
| NCT00267475 | Not specified | COMPLETED | Data Bank for Eosinophilic Disorders |
| NCT01779154 | Not specified | WITHDRAWN | Eosinophilic Gastrointestinal Disorders Patient Registry |
| NCT02897271 | Not specified | COMPLETED | Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort |
| NCT05719727 | Not specified | UNKNOWN | Primary Eosinophilic Colitis in Symptomatic Patients. |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.